Abstract
Targeting of human cancer stem cells (CSCs) requires the identification of vulnerabilities unique to CSCs versus healthy resident stem cells (SCs). Unfortunately, dysregulated pathways that support transformed CSCs, such as Wnt/β-catenin signaling, are also critical regulators of healthy SCs. Using the ICG-001 and CWP family of small molecules, we reveal Sam68 as a previously unappreciated modulator of Wnt/β-catenin signaling within CSCs. Disruption of CBP-β-catenin interaction via ICG-001/CWP induces the formation of a Sam68-CBP complex in CSCs that alters Wnt signaling toward apoptosis and differentiation induction. Our study identifies Sam68 as a regulator of human CSC vulnerability.
Keywords:
CBP; SUMOylation; Sam68; Wnt/β-catenin; cancer stem cells; differentiation; drug; leukemia; selectivity.
Crown Copyright © 2017. Published by Elsevier Ltd. All rights reserved.
MeSH terms
-
Adaptor Proteins, Signal Transducing / antagonists & inhibitors
-
Adaptor Proteins, Signal Transducing / genetics
-
Adaptor Proteins, Signal Transducing / metabolism*
-
Adult
-
Aged
-
Animals
-
Apoptosis / drug effects
-
Azabicyclo Compounds / pharmacology
-
Breast Neoplasms / metabolism
-
Breast Neoplasms / pathology
-
Bridged Bicyclo Compounds, Heterocyclic / pharmacology
-
Cell Differentiation / drug effects
-
Cells, Cultured
-
Colonic Neoplasms / metabolism
-
Colonic Neoplasms / pathology
-
DNA-Binding Proteins / antagonists & inhibitors
-
DNA-Binding Proteins / genetics
-
DNA-Binding Proteins / metabolism*
-
Female
-
Humans
-
Leukemia, Myeloid, Acute / metabolism
-
Leukemia, Myeloid, Acute / pathology
-
Male
-
Mice
-
Mice, Inbred NOD
-
Middle Aged
-
Neoplastic Stem Cells / cytology
-
Neoplastic Stem Cells / metabolism*
-
Neoplastic Stem Cells / transplantation
-
Organophosphates / pharmacology
-
Peptide Fragments / antagonists & inhibitors
-
Peptide Fragments / genetics
-
Peptide Fragments / metabolism*
-
Proto-Oncogene Proteins c-myc / metabolism
-
Pyrimidinones / pharmacology
-
RNA Interference
-
RNA-Binding Proteins / antagonists & inhibitors
-
RNA-Binding Proteins / genetics
-
RNA-Binding Proteins / metabolism*
-
Sialoglycoproteins / antagonists & inhibitors
-
Sialoglycoproteins / genetics
-
Sialoglycoproteins / metabolism*
-
Sumoylation / drug effects
-
Transcriptome / drug effects
-
Wnt Signaling Pathway / drug effects
-
beta Catenin / metabolism
Substances
-
Adaptor Proteins, Signal Transducing
-
Azabicyclo Compounds
-
Bridged Bicyclo Compounds, Heterocyclic
-
CWP232228
-
DNA-Binding Proteins
-
ICG 001
-
KHDRBS1 protein, human
-
Organophosphates
-
Peptide Fragments
-
Proto-Oncogene Proteins c-myc
-
Pyrimidinones
-
RNA-Binding Proteins
-
Sialoglycoproteins
-
beta Catenin
-
bone sialoprotein (35-62), human